Long-Term Safety and Efficacy of Deutetrabenazine in Younger and Older Patients With Tardive Dyskinesia

•What is the primary question addressed by this study?This post hoc analysis of a long-term open-label extension study evaluated the efficacy and safety of treatment with deutetrabenazine in younger (

Saved in:
Bibliographic Details
Published in:The American journal of geriatric psychiatry 2022-03, Vol.30 (3), p.360-371
Main Authors: Sajatovic, Martha, Finkbeiner, Stacy, Wilhelm, Amanda, Barkay, Hadas, Chaijale, Nayla, Gross, Nicholas, Gordon, Mark Forrest
Format: Article
Language:English
Subjects:
Adrenergic Uptake Inhibitors - adverse effects
Aged
Clinical outcomes
Clinical significance
Deutetrabenazine
Drug administration
Drug therapy
Dyskinesia
efficacy
elderly
Geriatrics
Humans
Middle Aged
Quality of Life
safety
tardive dyskinesia
Tardive Dyskinesia - chemically induced
Tardive Dyskinesia - complications
Tardive Dyskinesia - drug therapy
Tetrabenazine - adverse effects
Tetrabenazine - analogs & derivatives
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•What is the primary question addressed by this study?This post hoc analysis of a long-term open-label extension study evaluated the efficacy and safety of treatment with deutetrabenazine in younger (
ISSN:1064-7481
1545-7214
DOI:10.1016/j.jagp.2021.08.003